Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13
Alba Redin, Pilar Ciruela, Mariona Fernández de Sevilla, Fréderic Gómez-Bertomeu, Sebastià González‐Peris, Miguel Ángel Benítez, Glòria Trujillo, Álvaro Díaz, Erin Jou, Conchita Izquierdo, Mar Olga Pérez-Moreno, F.A. Moraga Llop, Montserrat Olsina, Belén Viñado, Esther Sanfeliu, A. García, S. Gonzalez-di Lauro, Juan José García‐García, Ángela Domı́nguez, Raquel Sá‐Leão, Carmen Muñoz‐Almagro
Abstract
We found that with the incorporation of the PCV13 vaccine, the numbers of IPD cases caused by serotypes included in this vaccine decreased in all of the age groups. Still, there was an unforeseen increase of the serotypes not included in this vaccine causing IPD, especially in the >65-year-old group. Moreover, a significant increase of serotype 3 included in the vaccine has been observed; this event has been reported by other researchers. These facts call for the incorporation of more serotypes in future vaccines and a more thorough surveillance of the dynamics of this microorganism.